We are devoted to strengthening emerging pharmaceutical markets. To this end, we commit to upholding essential principles in all of our dealings with clients. Our Client Charter is our promise to you that ...
Our Quality Edge is how we blend Empathy, Reliability and Responsiveness to deliver exceptional service to all our clients.
We Partner with Clients to execute Outcomes Research in emerging markets.
We develop results-driven market access solutions for clients in emerging markets.
We are devoted to strengthening emerging pharmaceutical markets.
Market Access Solutions
Innovative Access Strategies
Our Quality Edge
What healthcare funders want from competition inquiry. phrmaccess.com/x/nr pic.twitter.com/CoGkAvhHht
About 3 days ago from Carapinha & Company's Twitter
State hospitals have all the oncology tech — but no specialists to use it. phrmaccess.com/x/nt pic.twitter.com/RXOlYveJFR
Improving Patient Pharmaceutical Access Via Value-Based Pricing Benchmarks. phrmaccess.com/x/ne pic.twitter.com/1d3SEScoUh
Last week from Carapinha & Company's Twitter
SA pharmaceutical sector provides unlimited opportunities. phrmaccess.com/x/nf pic.twitter.com/0w07giR1vG
Azar back for more Senate questions on Trump drug plan. phrmaccess.com/x/n8 pic.twitter.com/ntUxmpWmqZ
First Marijuana-Based Medicine Is Approved for Sale in U.S.. phrmaccess.com/x/n9 pic.twitter.com/arVXBYXRYE
South Africa cannot afford the proposed NHI. phrmaccess.com/x/n5 pic.twitter.com/vBgO4ra3jP
About a week ago from Carapinha & Company's Twitter
Start-ups take fight to India’s superbugs. phrmaccess.com/x/n6 pic.twitter.com/uQDKAZfpC6
MSF probes allegations of sexual abuses in Africa. phrmaccess.com/x/mw pic.twitter.com/gyoQOMWHNn
About 2 weeks ago from Carapinha & Company's Twitter
Massachusetts Sues OxyContin Maker Purdue Pharma, Saying It ‘Peddled Falsehoods’. phrmaccess.com/x/md pic.twitter.com/IVQ0q9Grvv
About 3 weeks ago from Carapinha & Company's Twitter
Medical cannabis and the challenge for regulation of medicines. phrmaccess.com/x/le
Last month from Carapinha & Company's Twitter